Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Magnus Nylander Biocare Aktiebolag
AB
Active
Org 5561016139
Mälbyvägen 44, 764 91
Väddö
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1965
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Magnus Nylander Biocare Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
314
247
92
52
619
Staff expenses
—
—
—
—
—
EBITDA
41
33
−343
−7
99
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
41
33
−343
−7
99
Net financials
—
52
1
2
7
Profit before tax
41
67
−342
−5
125
Tax
−0
−14
−0
−0
−0
Net profit
41
53
−342
−5
125
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
475
775
747
392
789
Equity
415
468
126
121
246
Long-term debt
0
0
0
0
0
Short-term debt
59
288
602
252
544
Total debt
59
288
602
252
544
Financial ratios
5-year trend
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
2020
2024
Equity ratio
31.2%
This company
38.2%
Market median
+18% vs market
2020
2024
Return on equity
50.8%
This company
18.4%
Market median
+176% vs market
2020
2024
Net profit margin
20.2%
This company
8.1%
Market median
+149% vs market
2020
2024
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
2020
2024
Debt / equity
2.21×
This company
0.62×
Market median
-256% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Magnus Nylander Biocare Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
